glp-1 drug ingredients Optimizer Bundle GLP-1 Daily Support
Description
Methods We conducted a population-based propensity-matched retrospective cohort study using TriNetX
Only 40% of 2023 initiators remained on therapy after a year compared to 34% of 2022 initiators and 33% of 2021 initiators
It is given as an injection under the skin (subcutaneously), every 2 weeks or once a month
Looking for alternatives to Mounjaro for weight loss
In late March 2026, Hims & Hers Health, Inc
